Fennec Pharmaceuticals
Stock Forecast, Prediction & Price Target
Fennec Pharmaceuticals Financial Estimates
Fennec Pharmaceuticals Revenue Estimates
Fennec Pharmaceuticals EBITDA Estimates
Fennec Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $1.53M 0% | $21.25M 1284.49% | Avg: $67.20M Low: $53.61M High: $86.27M avg. 216.23% | Avg: $94.58M Low: $74.20M High: $120.18M avg. 40.73% | Avg: $114.23M Low: $89.62M High: $145.16M avg. 20.78% | Avg: $139.44M Low: $109.40M High: $177.18M avg. 22.06% |
Net Income
% change YoY
| $-17.45M N/A | $-24.83M -42.29% | $-16.04M 35.40% | Avg: $16.37M Low: $-9.83M High: $35.34M avg. 202.06% | Avg: $48.67M Low: $14.61M High: $68.29M avg. 197.20% | Avg: $71.74M Low: $51.65M High: $97.00M avg. 47.41% | Avg: $102.57M Low: $73.85M High: $138.67M avg. 42.96% |
EBITDA
% change YoY
| $-17.18M N/A | $-22.54M -31.17% | $-12.36M 45.15% | Avg: $-8.07M Low: $-10.36M High: $-6.44M avg. 34.67% | Avg: $-11.36M Low: $-14.44M High: $-8.91M avg. -40.73% | Avg: $-13.72M Low: $-17.44M High: $-10.77M avg. -20.78% | Avg: $-16.75M Low: $-21.29M High: $-13.14M avg. -22.06% |
EPS
% change YoY
| -$0.67 N/A | -$0.95 -41.79% | -$0.6 36.84% | Avg: $0.59 Low: -$0.37 High: $1.33 avg. 198.05% | Avg: $1.78 Low: $0.55 High: $2.57 avg. 201.98% | Avg: $2.7 Low: $1.94 High: $3.65 avg. 51.96% | Avg: $3.86 Low: $2.78 High: $5.22 avg. 42.96% |
Operating Expenses
% change YoY
| $17.22M N/A | $24.03M 39.56% | $32.76M 36.30% | Avg: $1.25B Low: $998.05M High: $1.60B avg. 3718.32% | Avg: $1.76B Low: $1.38B High: $2.23B avg. 40.73% | Avg: $2.12B Low: $1.66B High: $2.70B avg. 20.78% | Avg: $2.59B Low: $2.03B High: $3.29B avg. 22.06% |
FAQ
What is Fennec Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 122.41% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -9.83M, average is 16.37M and high is 35.34M.
What is Fennec Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 74.95% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $53.61M, average is $67.20M and high is $86.27M.
What is Fennec Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 123.74% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$0.37, average is $0.59 and high is $1.33.
What is the best performing analyst?
In the last twelve months analysts have been covering Fennec Pharmaceuticals stock. The most successful analyst is Raghuram Selvaraju.